Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Sixty-one percent of physicians in the U.S. agree Amazon will help reduce the cost of medications, according to a recent survey by DRG Digital.
The FDA approved BioMarin Pharmaceutical's therapy for adults with the rare inherited disorder phenylketonuria, the drugmaker announced May 24.
The FDA granted market clearance to T2 Biosystems' test to detect sepsis-causing bacterial pathogens in blood samples, the company announced May 29.
Medline raised $2,500 for the Children's Burn Foundation during the American Burn Association's annual meeting April 9-13 in Chicago.
Formalizing continuous process improvement offers hospitals numerous benefits, including an organizational commitment to excellence, reduced waste and increased operating efficiency.
While a majority of drug industry executives do not view Salt Lake City-based Intermountain Healthcare's newly formed generic drug company as a threat, most healthcare providers say they'd do business with the new venture, according to a report from Reaction…
The American Red Cross often sees a steep drop in blood donations starting around Memorial Day and continuing through the summer, due to vacations and school breaks.
Here are the six latest drugs or medical devices approved by the FDA since May 11.
The FDA on May 21 approved Dova Pharmaceuticals' drug Doptelet to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical or dental procedure.
After two rejections, the FDA finally approved AstraZeneca's potassium drug Lokelma, the drugmaker announced May 18.